| INTRODUCTION
The biological bases of major psychiatric disorders have been studied for decades, yet they remain largely unresolved. Evidence from both clinical and biomedical literature has demonstrated that individuals with these conditions show differences in circulating immunologic markers, functional capacities of isolated immune cells, and atypical prevalence of clinical immune-related phenotypes compared to individuals not affected by psychiatric or neurodevelopmental disorders (Dowlati, 2010; Eaton et al., 2006; Fineberg & Ellman, 2013; Gesundheit et al., 2013; Gibney & Drexhage, 2013; Hess et al., 2016; Jones & Thomsen, 2013; Masi et al., 2015; Modabbernia, Taslimi, Brietzke, & Ashrafi, 2013; Rege & Hodgkinson, 2013) . It remains unclear what roles (if any) altered immunologic functions may play in the major psychiatric phenotypes, though plausible mechanisms linking altered immune functions with neurobiological changes during early brain development and in fully developed adults have been identified (Deverman & Patterson, 2009; Felger & Lotrich, 2013; Meyer, 2014; Miller, Haroon, Raison, & Felger, 2013; Oskvig et al., 2012; Sekar et al., 2016; Shatz, 2009; Smith, Li, Garbett, Mirnics, & Patterson, 2007) . While some studies have already suggested potential genetic bases for the immune dysregulation observed in a subset of psychiatric patients (Jung, Kohane, & Wall, 2011; Stringer, Kahn, In the present study, we leveraged existing data to explore the genetic associations of a set of medical phenotypes that are enriched with immune and inflammatory processes; these included allergic conditions, classic autoimmune diseases, other inflammatory diseases, and vulnerability to infectious disease. We sought to crosscorrelate the genetic associations of these phenotypes with the associations obtained from studies of a set of psychiatric and behavioral phenotypes. We hypothesized that some phenotype-pairs with evidence for increased clinical comorbidity might also share similarities in their genome-wide association profile, which would be reflected in our analyses as significant positive correlations. Additionally, in light of literature suggesting shared genetic risk among some immune and inflammatory disorders, we assessed genetic correlations within this set of phenotypes using the LDSC method; these findings are reported within the Supporting Information. Genetic correlations within the set of psychiatric phenotypes have been reported previously (Anttila, 2016; Bulik-Sullivan, Finucane, et al., 2015a; Zheng et al., 2016) and are not examined in the present study.
| MATERIALS AND METHODS

| Literature search
We searched the published literature (Pubmed, SCOPUS), data repositories (dbGaP and immunobase.org), and the downloads page of the Psychiatric Genomics Consortium (PGC) website (https://www.med.
unc.edu/pgc/downloads) to identify phenotypes with potentially usable GWAS and GWAS meta-analysis summary statistics. For studies identified in the published literature, we contacted corresponding authors to request summary statistics. In order to facilitate crossstudy comparison, we utilized studies that reported samples of European ancestry, broadly defined to include Central, Southern and Eastern Europe, Scandinavia, and Western Russia. Our initial search yielded a large number of datasets reflecting a wide range of behavioral and immune-related phenotypes (Supporting Information   Table S1 ); the set of phenotypes ultimately retained for final analyses was selected based on criteria described below. When multiple studies were identified for a given phenotype, we pursued the studies with the largest effective sample sizes and ultimately used the available study with the largest heritability z-score. In several instances, data from the largest existing studies could not be shared or reflected a mixed-ancestry meta-analysis; in these cases, we deferred to the next largest European-ancestry study. We chose to retain datasets with an effective sample size greater than 5,000 individuals and with estimated SNP heritability z-score ≥3, in keeping with previous recommendations (Bulik-Sullivan, Finucane, et al., 2015a) . This filter resulted in the exclusion of many relevant immune-related phenotypes, including eosinophilic esophagitis (Sleiman et al., 2014) , granulomatosis with polyangiitis (Xie et al., 2013) , IgA nephropathy (Kiryluk et al., 2014) , HIV-related neurocognitive phenotypes (Levine et al., 2012) , morning cortisol levels (Bolton, 2014) , myeloid leukemias (Tapper et al., 2015) , psoriatic arthritis , sarcoidosis (Fischer et al., 2012) , and systemic sclerosis (Radstake et al., 2010) . This also resulted in exclusion of several psychiatric and behavior phenotypes, including adolescent alcohol abuse (Edwards et al., 2015) , anxiety-spectrum disorders (Otowa et al., 2016) , borderline personality disorder (Lubke et al., 2014) , language impairment (Jernigan et al., 2016) , personality domains (five factor model; de Moor et al., 2012) , post-traumatic stress disorder (Duncan, 2017a) , and reading disability (Eicher et al., 2013) . We also ultimately excluded data from studies of ethanol, opiate, and cocaine dependence (Gelernter, Kranzler, Sherva, Almasy, et al., 2014a; Gelernter, Kranzler, Sherva, Koesterer, et al., 2014b; Gelernter, Sherva, et al., 2014c) , as genetic correlations involving these phenotypes were frequently outside the boundaries tolerated by the LDSC software, making them difficult to interpret; this may have been related to the ordinal-ranked phenotypes used in the GWASs. Finally, while relationships between tobacco-smoking behavior and other psychiatric phenotypes have been examined previously (Bulik-Sullivan, Finucane, et al., 2015a; Zheng et al., 2016) , we chose to retain smoking data in order to assess relationships with a more complete set of immunerelated phenotypes. The full list of phenotypes identified in the search and retained for analyses is shown in Supporting Information Table S1 , along with identification of the study cohorts and consortia that generated these data, full citations of the respective publications, and indications of sample size, information regarding genomic inflation, and estimated SNP heritability.
| GWAS phenotypes retained for genetic correlation
For our psychiatric and behavior-related phenotypes, we ultimately retained GWAS summary data reflecting studies of Alzheimer's disease (Lambert et al., 2013) , angry temperament (Mick et al., 2014) , anorexia nervosa (Duncan et al., 2017b) , attention deficithyperactivity disorder (ADHD; Demontis, 2017) , autism (Anney, 2017) , bipolar disorder (BD; Hou et al., 2016; Sklar et al., 2011) , cigarette smoking (ever-smoked status; The Tobacco & Genetics Consortium, 2010), major depressive disorder , trait neuroticism (Turley et al., 2018) , obsessive-compulsive disorder (OCD; Arnold, 2017), Parkinson's disease , schizophrenia (SZ; Ripke, 2014) , and Tourette Syndrome (personal communication from PGC Working Group). Collectively, these phenotypes were treated as a set. For phenotypes that are known or suspected to involve alterations to immune cells and/or inflammatory signaling, we ultimately retained GWAS data reflecting allergy (any, self-reported; Hinds et al., 2013; Pickrell et al., 2016) , asthma (selfreported; Pickrell et al., 2016) , atopic dermatitis (EArly Genetics and Lifecourse Epidemiology (EAGLE) Eczema Consortium, 2015), childhood ear infection (self-reported; Pickrell et al., 2016) , celiac disease (Dubois, 2010) , serum C-reactive protein (CRP; Dehghan, 2011), Crohn's disease (CD; Franke et al., 2010; Liu et al., 2015) , hypothyroidism (self-reported; Pickrell et al., 2016) , primary biliary cirrhosis (PBC; Cordell, 2015) , psoriasis (Tsoi et al., 2015) , rheumatoid arthritis (Okada et al., 2014) , systemic lupus erythematosus (SLE; Bentham et al., 2015) , susceptibility to pulmonary tuberculosis (Curtis et al., 2015) , type 1 diabetes (Bradfield et al., 2011) , and ulcerative colitis (UC; Anderson, 2011; Liu et al., 2015) These phenotypes were treated as a set in subsequent analyses.
| Data pre-processing and analysis
Our primary analyses were performed using the LDSC software (https://github.com/bulik/ldsc; Bulik-Sullivan, Finucane, et al., 2015a) . Briefly, this set of tools can be used with existing GWAS summary data in order to distinguish polygenicity from confounding caused by uncontrolled population stratification or cryptic relatedness among samples (Bulik-Sullivan, Loh, et al., 2015b) , to estimate the heritability of a given phenotype (Bulik-Sullivan, Finucane, et al., 2015a) , and to estimate the genetic correlation between two phenotypes based on two separate or related sets of summary statistics (Bulik-Sullivan, Finucane, et al., 2015a) . In the latter application, the minimal requirements for each set of summary statistics include columns of data indicating SNP ID, the identities of reference and nonreference alleles, association p-value, effect size, test statistic (e.g., odds ratio, regression β, or Z-score), and sample size (per SNP or for all SNPs). For each pair of phenotypes, this tool compares the strength and direction of association signal at each locus while correcting for the correlation that would be expected based on genetic linkage alone, and it provides an estimate of the genetic correlation between phenotypes. This method relies on adjustment for the linkage between SNPs (i.e., covariance caused by genomic proximity); for our analyses, we used the set of LD scores provided by the software's creators, based on the 1000 Genomes Project's European sample (file (Berisa & Pickrell, 2015) . Following the developers' practices, we assumed no sample overlap for comparisons of data generated by different consortia (Shi et al., 2017) .
3 | RESULTS 3.1 | Genome-wide correlations between psychiatric and immune-inflammatory phenotypes Additionally, several large-magnitude correlations attained a nominal threshold of statistical significance (e.g., autism-allergy and OCD-celiac); these correlations tended to have a higher standard error and were generated using relatively smaller GWAS sample sizes. As such, they may be more likely to reflect false positives and should be regarded with appropriate skepticism.
For phenotypes involved in correlations that survived multiple test correction, estimated SNP heritability is shown in Table 2 . For these phenotypes, we reassessed SNP heritability and the magnitude of genome-wide genetic correlations using the HESS method (Tables 1 and 2 ). Correlation coefficients were not correlated between the two methods (Pearson r = 0.25, p = 0.25; Supporting Information Figure S1 ) and the absolute value of the difference was negatively related to sample size (r = −0.45, p = 0.035; Supporting Information Figure S2 ), which is consistent with the software developer's guidelines (Shi et al., 2017) . LDSC-based correlations among the immunerelated phenotypes are reported in the Supporting Information Text and Table S5 .
| Characterization of loci contributing to psychiatric-immune genetic correlations
For psychiatric-immune phenotype-pairs that demonstrated a significant genome-wide correlation with the LDSC method (i.e., those in Table 1 ), we used the HESS software to examine the genetic correlation within the~1,694 partitioned genomic loci. The number of correlated loci before and after BH multiple test correction are depicted FIGURE 1 A heatmap depicting LDSC genome-wide genetic correlations between psychiatric and immune-related conditions such that red reflects more positive correlation coefficients while blue reflects more negative coefficients. Correlation coefficients are provided within each cell, with full details provided in Supporting Information Table S2 . Correlations reaching trend-level significance (.05 < uncorrected p < .10) are depicted as colored panels, while relationships surpassing uncorrected p < .05 are additionally denoted with *, and relationships surpassing BH-p < .05 (for the total number of tests depicted in the figure) are denoted with **. The rows and columns of the heatmap are hierarchically clustered based on correlation coefficients. ADHD = attention deficit-hyperactivity disorder; OCD = obsessive-compulsive disorder [Color figure can be viewed at wileyonlinelibrary.com]
in Table 3 ; detailed results for these analyses, including local heritability, correlation strength, and the lists of gene symbols within each loci are provided in Supporting Information Table S3 . Only SZ displayed robust local genetic correlations with immune-related phenotypes, including thirty-two loci with CD, 37 loci with PBC, 20 loci with SLE, and 8 with UC (Table 3 , depicted in Figure 2 ). Upon closer examination of the loci implicated between SZ and CD, we noticed that five of these loci contained GW hits, including one locus on chromosome 4q24 (4:100678360-103221356; highlighted green in Figure 2 ) that contained GW hits for both SZ and CD within the present data, and with four other autoimmune diseases (immunobase. org); these signals are near autoimmunity candidate genes NFKB1
and MANBA, as well as proposed SZ candidate gene SLC39A8, among others contained within the locus (see Supporting Information Among the loci implicated between SZ and UC, one within 11q13.1 (11:63804569-65898631) harbored GW hits for multiple autoimmune disorders.
We also sought to examine whether the specific loci might be implicated across multiple psychiatric-immune disorder pairs (Figure 2 ). An analysis limited to only those surviving BH correction for multiple testing yielded only two loci shared by multiple disease pairs. The first locus (within 3p24.3; 3:21643707-22204244) was identified in correlations of SZ with PBC and with CD; it contained no GWS hits and two genes of unclear consequence ZNF385D and ZNF385D-AS2. The second locus within 8p32.1 (8:11278998-13491775, highlighted brown) was identified in correlations of SZ with PBC and with SLE; this locus contained numerous genes and is adjacent to a GWS hit for SLE associated with candidate gene BLK.
When we broadened the scope to examine all loci implicated in nominally significant correlations (uncorrected p < 0.05), we find several that are common to multiple psychiatric-immune disorder pairs Note. This table displays psychiatric-immune phenotype-pairs showing genome-wide genetic correlation with the linkage disequilibrium score regression (LDSC) method after correction for the total number of genetic correlations depicted in Figure 1 using the Benjamini-Hochberg (BH) method. We also report the genome-wide correlation estimates produced by the heritability estimation from summary statistics (HESS) method. ADHD = attention deficit-hyperactivity disorder; BD = bipolar disorder; CD = Crohn's disease; CRP = C-reactive protein; OCD = obsessive compulsive disorder; PBC = primary biliary cirrhosis; SLE = systemic lupus erythematosus; SZ = schizophrenia; UC = ulcerative colitis.
( Table 4 ). The most widely implicated locus was shared among the five pairs of psychotic and inflammatory bowel disorders (within 17q12; 17:36809344-38877404, highlighted purple) and contains a GW hit for BD ascribed to candidate gene ERBB2. There were another eight loci that were implicated in four disorder pairs. Among these, one located within 1q32.1 (1:200137649-201589975, highlighted purple) contains GW hits for multiple autoimmune disorders (including celiac disorder, CD, multiple sclerosis, and UC) and is near candidate genes CACNA1S and KIF21B. The full list of loci implicated across multiple disorder pairs is available in Supporting Information Table S3 . The results of the HESS analysis of putative causal directionality (Table 5) of psychiatric and immune-related phenotypes using two methods to estimate genetic correlation from summary statistics. We used updated versions of psychiatric GWASs (Anney, 2017; Arnold, 2017; Demontis, 2017; Psychiatric GWAS Consortium Bipolar Disorder Working Group, 2011) , and compiled a more comprehensive set of immune-related phenotypes, while simultaneously reducing the burden imposed by multiple testing. Additionally, this analysis reflects the first application of the LDSC and HESS method for some of these phenotype-pairs. We identified several genome-wide correlations that were robust to multiple testing. Furthermore, we used the HESS method to validate genome-wide correlations and to conduct a quantitative analysis that localizes correlations to regions of the genome. We prioritized the reporting of findings based on co-localization with GW hits. As such, this study provides a quantitative map of genetic relationships between psychiatric and immune-related disorders and serves, along with previous work (Wang et al., 2015) , as a starting point for identifying and characterizing potentially pleiotropic loci.
Prominent among the LDSC genome-wide significant findings was a cluster of modest positive correlations involving BD (rgs ranging 0.25 to 0.33) and SZ (rgs ranging 0.12 to 0.15) in conjunction with immunerelated disorders involving the gastrointestinal tract (i.e., CD, PBC, UC).
These findings are consistent with available epidemiological evidence indicating that the presence of one set of disorders portends increased risk for a diagnosis from the other class of disorders, though the Note. This table displays phenotype names, data sources, and estimated SNP heritability using the linkage disequilibrium score regression (LDSC) and heritability estimation from summary statistics (HESS) methods, as well as the GWAS sample size and number of SNPs surviving quality control. Full publication references, consortia names, links to web resources, and additional details on the original studies are provided in Supporting Information Table S1 . GWAS N denoted with * indicates the median N for all SNPs. ADHD = attention deficit-hyperactivity disorder; BD = bipolar disorder; CD = Crohn's disease; CRP = C-reactive protein; OCD = obsessive compulsive disorder; PBC = primary biliary cirrhosis; PGC = Psychiatric Genomics Consortium; QC = quality control; SNP = single nucleotide polymorphism; SLE = systemic lupus erythematosus; SZ = schizophrenia; UC = ulcerative colitis.
causality and temporality of these relationships is not clearly estab- yielded 97 loci that were robust to multiple test correction, 18 of which also were shown to harbor GW hits in previous studies. In several instances, these GW hits localize near genes with functions that are pleiotropic and relevant to both brain and immune system phenotypes. For example, we identified a SZ-CD correlated locus at 4q24
(4:100678360-103221356) that contained GW hits for both SZ (putatively attributed to SLC39A8) and several autoimmune diseases (putatively attributed to NFKB1 and MANBA); others have proposed that associations at this locus may exert pleiotropic effects on a wide range of phenotypes (additionally including body mass index, serum levels of Tourette's syndrome-allergy 0/0
Note. This table summarizes findings of local genetic correlation analysis, including the number of significantly correlated loci before and after BenjaminiHochberg (BH) correction for multiple testing (shown in bold). Loci that showed robust correlations were interrogated for co-localization with significant genome-wide associations (GWS hits, with p < 5 × 10
−8
). The chromosomal coordinates containing GWS signal are provided, along with associated genes. Proposed candidate genes are highlighted with bold text. ADHD = attention deficit-hyperactivity disorder; BD = bipolar disorder; BH = Benjamini-Hochberg; CD = Crohn's disease; CEA = childhood ear infection; HPT = hypothyroidism; NC-H = comparison; OCD = obsessive compulsive disorder; PBC = primary biliary cirrhosis; RA = rheumatoid arthritis; SLE = systemic lupus erythematosus; SZ = schizophrenia; UC = ulcerative colitis. manganese, N-terminal pro-B-type natriuretic peptide, and HDL-cholesterol) through a functional variant found in European populations affecting the SLC39A8 cation transporter (Costas, 2017; Li et al., 2016) . A locus within 11q23.3 (11:117747110-119215476) was significantly correlated between SZ and PBC and harbors a region of GW hits for multiple autoimmune disorders attributed to PLCL2, a catalytically inactive phospholipase-like protein thought to influence intracellular signaling, calcium homeostasis, and GABA-ergic receptor trafficking in immune and neuronal cell types, among others (Murakami, Matsuda, Harada, & Hirata, 2017; Takenaka et al., 2003; Toyoda et al., 2015) . A de novo missense mutation affecting this gene was identified in an exome sequencing study of SZ affected individuals, though no replication appears to have been reported (Xu et al., 2011) . Similarly, a correlated locus within 22q13.1 (22:39307894--40545797, highlighted yellow in Figure 2 ) contains GW hits for PBC, which overlaps with voltage-gated calcium channel gene CACNA1I; this gene has been implicated by both GWAS and rare-variant studies of SZ (Andrade et al., 2016; Ripke, 2014) . Another correlated locus within 11q23 (11:118579747-118743772) contained GW hits for multiple autoimmune disorders and is suspected to exert pleiotropic effects through several genes, whose functions include repression of aberrant interferon signaling (DDX6; Lumb et al., 2017) , chemokine signaling between T-helper and B-cells (CXCR5; Papp, Szabó, Szekanecz, & Zeher, 2014; Vaeth et al., 2014) , and enzymatic break down of microbial disaccharides (TREH; Muller et al., 2013) . Notably, functional genomic studies have identified DDX6 as a gene that is perturbed during neuronal differentiation of samples derived from individuals with schizophrenia (Maschietto et al., 2015) , and as a peripheral blood marker of cerebrospinal fluid serotonin metabolite levels (Luykx et al., 2016) , supporting its relevance to psychiatric phenotypes.
We also examined loci that showed a nominal genetic correlation across multiple disorder pairs, and found these loci also harbored GW FIGURE 2 This figure depicts the HESS local genetic correlation data with respect to the genome and previously reported genome-wide association signals for respective disorders. A model genome using HG19 coordinates is depicted in gray. Moving outward from the center of the plot, the first track containing a red histogram depicts loci significantly associated with SZ (GWAS p < 5 × 10 −8 ), with larger peaks indicating more significance (plotted as −log(p-value)). The second track (labeled SZ-CD) depicts regions of genetic correlation between SZ and CD, such that blue reflects uncorrected p < .05 and red reflects BH-corrected p < .05. The next track (labeled CD Hits) contains a histogram depicting CD GWAS signal as described previously. The next pair of tracks depict genetic correlations for SZ-PBC and PBC GWAS signal, respectively. The third pair of tracks depicts this information for SZ-SLE (with SLE GWAS signal). The fourth pair of tracks depicts this information for SZ-UC and UC GWAS signal, respectively. In the center of the plot, we identify several GWAS candidate genes using colored text and arrows to indicate the pertinent locus; colored text and arrows are used to indicate the relevant phenotype-pairs, such that green = SZ-CD, orange = SZ-PBC, yellow = SZ-SLE, brown = SZ-PBC/SLE, and purple = SZ/BD-CD/PBC/UC [Color figure can be viewed at wileyonlinelibrary.com] hits for respective phenotypes. The locus at 17q12 shared among multiple disorders contains a GW hit for BD (17:36809344-38877404) ascribed to candidate gene ERBB2 (Hou et al., 2016) . This gene and its relatives encode receptor tyrosine kinases that interact with a family of growth factors called neuregulins to regulate the assembly of neural circuitry, myelination, neurotransmission and synaptic plasticity. A large body of evidence implicates both ligands and receptors from these families as susceptibility genes for SZ and BD (Mei & Nave, 2014) . Notably, ERBB2 overlaps with GW hits for multiple autoimmune disorders, though these have been attributed to different genes in the region. Another locus at 1q32.1
(1:200137649-201589975) contains GW hits for multiple autoimmune disorders (including celiac disease, CD, multiple sclerosis, and UC) and is near candidate genes C1orf106, CACNA1S, GPR25, and KIF21B. Genetic disruptions of voltage-gated calcium channels, including CACNA1S, are well-established susceptibility factors in psychiatric and neurological disorders (Heyes et al., 2015; Schmunk & Gargus, 2013) . KIF21B encodes a neuronal motor protein implicated in GABA A receptor trafficking (Labonte, Thies, & Kneussel, 2014) , in addition to having a suspected role in regulating inflammatory signaling in several lymphocyte subtypes (Goris, Boonen, D'hooghe, & Dubois, 2010) .
While it is tempting to speculate about these observations, we must acknowledge limitations and caveats of the present approach.
Current methods for assessing genetic correlations are not well suited for fine-mapping shared liability across disorders; other methods are better suited for this task, including extensions of GWAS that model multiple phenotypes simultaneously (Cotsapas, 2011; Porter & O'Reilly, 2017; Turley et al., 2018; Wang et al., 2015) .
With respect to local genetic correlations, we have prioritized reporting of loci that co-localize with GW hits. However, this implies that the presence of the GW hit is contributing to the observed correlation, which we have not demonstrated presently. As such, our discussion of potentially pleiotropic loci and candidate genes should be considered anecdotal at this time. One indirect approach to assessing the role of GW hits in a local genetic correlation might be to reestimate the local correlation after the removal of the smaller region of GW signal from the original datasets. When we conducted this analysis for the SZ-CD pair, we found that the number of significant loci (BH p < 0.05) was reduced from 32 to 8, suggesting that GW hits likely play an important role in many of the local genetic correlations.
Future studies will be able to combine larger GWAS sample sizes with new methods aimed at stratifying genetic correlations by biological annotations (e.g., tissue type or signaling pathways) in order to more precisely define the parts of the genome that mediate a genetic correlation (Lu et al., 2017) . Note. This table depicts the loci that showed significant (uncorrected p < .05) correlations across multiple pairs of phenotypes. Bold font denotes phenotype-pairs for which the locus survived BH multiple test correction. The ** symbol denotes loci at which multiple autoimmune disorders show an association reaching genome-wide significance (per immunobase.org). Bold font is also used to indicate proposed candidate genes. BD = bipolar disorder; CD = Crohn's disease; GWS = genome-wide significance defined as
; HPT = hypothyroidism; PBC = primary biliary cirrhosis; SLE = systemic lupus erythematosus; UC = ulcerative colitis.
results. Using several approaches that were not dependent on the directionality of a given SNP's effect, Wang and colleagues concluded that many (24 of 35) pairs of psychiatric and immune-related phenotypes shared a statistically significant proportion of risk-associated loci; among these findings was a significant genetic overlap between BD (as well as SZ) and UC (Wang et al., 2015) . However, many of the other relationships identified in that study were not significant in the present study. Another recent study demonstrated that polygenic risk scores reflecting additive risk for several autoimmune diseases can explain a small proportion of variance in SZ case-control status, yet the genome-wide significant SNPs from the autoimmune GWASs were not over-represented among SZ's genome-wide significant hits when permutation-based analysis was performed (Pouget et al., 2016) . The apparent disagreement between different approaches for assessing shared genetic liability thus underscores the value of examining the consensus across studies and methods (Pouget et al., 2016) .
The LDSC approach featured here attempts to quantitate similarities and differences in association signals across the entire genome.
Some of our phenotype-pairs have been examined previously using genome-wide assessment methods, yielding apparently contradictory findings (Anttila, 2016; Bulik-Sullivan, Loh, et al., 2015b; Zheng et al., 2016) . For example, a previous study implementing a REML-based approach did not find significant SNP-based co-heritabilities between CD and the major psychiatric phenotypes (Lee et al., 2013) . Additionally, the first study implementing the LDSC method found no significant correlation (rg = 0.08 AE 0.08, uncorrected p = 0.33) between BD and UC (Bulik-Sullivan, Finucane, et al., 2015a) ; this study used a smaller dataset for BD (Sklar et al., 2011; N = 16,731 ) and a different version of the UC dataset (reported as Jostins et al., 2012; N = 27,432) . A similar non-correlation is also reported in LD-Hub (http:// ldsc.broadinstitute.org/), using what appears to be the same datasets, although referencing a related article (Liu et al., 2015; N = 27,432) .
The analyses portrayed in our main text utilized a larger BD dataset (Hou et al., 2016; N = 40,225) , the same dataset for UC (Liu et al., 2015; N = 27,432) , and uniform criteria for SNP retention based on inclusion in the HapMap3 panel and MAF ≥ 5% within the 1000
Genomes Project Phase 3 European samples. In order to resolve apparent discrepancies, we obtained additional versions of the available data for BD, SZ, CD, and UC and pre-filtered under both inclusive (imputation INFO score ≥ 0.9 or all SNPs, when INFO score unavailable) or exclusive criteria (MAF > 5% within the 1000
Genomes Project Phase 3 European samples). We found that correlations between SZ and each of CD, PBC, and UC tended to be more positive and more significant (i.e., reaching a BH-corrected threshold) when using the SZ data filtered at MAF > 5% (Supporting Information Figure S3) . A similar pattern held true for inclusive vs. (Lu et al., 2017) . Thus, our study suggests that genetic correlations between psychiatric and immune-related disorders may be more significant when analyses are restricted to common variation. Reassuringly, the developers of the HESS method use the same datasets examined presently, and also report positive genetic correlations between SZ and the inflammatory bowel disorders (Shi et al., 2017) .
The results of the HESS analysis of putative causal directionality indicate that the local genetic correlations are higher in loci occupied by SZ GW hits, as compared to the loci harboring hits for the paired autoimmune disorders (Shi et al., 2017) . This pattern is consistent with the hypothesis that genetic liability toward SZ tends to impart a greater genetic risk for the corresponding paired disorder, rather than the opposite directional hypothesis. A related interpretation may be there is an unobserved intermediate phenotype (e.g., a shared biological pathways/mechanism) that is pleiotropic for both measured phenotypes, but more strongly influences the SZ phenotype. This pattern of findings could also be caused by the presence of a confounding factor (e.g., smoking, socioeconomic status) that portends risk for both phenotypes (Shi et al., 2017) . Thus, we caution against overinterpretation of these findings. Extensions of Mendelian randomization methods to incorporate two GWAS samples using multi-allelic risk stratifying instruments will be better suited to address these hypotheses (Hartwig, Davies, Hemani, & Davey Smith, 2016) Other limitations of the HESS method, including assumptions related ; PBC = primary biliary cirrhosis; SLE = systemic lupus erythematosus; UC = ulcerative colitis.
to sample overlap and ancestry stratification, are discussed extensively by the method's developers (Shi et al., 2017) .
Our study also identified many phenotype-pairs that demonstrated significant genome-wide correlations using the LDSC method, but for which HESS-based genome-wide and local genetic correlations could not be identified. This is unsurprising, given that the sample sizes for these phenotypes were generally below the ). This could be consistent with two different sets of clinical observations. The first is that symptoms of depression are common in individuals with hypothyroidism, and that subclinical hypothyroidism could play a role in a subset of persons diagnosed with major depression; thus cross-contamination of GWAS samples could lead to a biased positive correlation. However, the second observation is that there is an increased incidence of major depression and depressive symptomatology in persons with autoimmune thyroiditis receiving hormone replacement therapy (Dayan & Panicker, 2013; Giynas Ayhan, Uguz, Askin, & Gonen, 2014) . It is worth noting that GWAS data for allergy, asthma, hypothyroidism, childhood ear infection, and Parkinson's disease were obtained through 23andMe, Inc. These data are based on self-report, and thus could be more susceptible to bias stemming from misdiagnosis or misreporting, though previous work supports their validity (Tung et al., 2011) . None the less, the samples sizes are an order of magnitude larger than many other datasets, resulting in smaller stan- ); this finds support in large registry-based studies indicating an increase in ADHD diagnosis in individuals with autoimmune disease (Nielsen, Benros, & Dalsgaard, 2017) , children with mother's affected by autoimmune disease (Nielsen et al., 2017) , and children of mothers with rheumatoid arthritis . Registry-based studies also provide support for increased inci- ), though a relatively large epidemiological study finds no association in affected individuals (Vogel et al., 2017) . The negative correlation between anorexia nervosa and CRP (rg = −0.30 AE 0.08, p = 1.0 × 10 −4
) is borne out in a recent meta-analysis of relevant studies (Solmi et al., 2015) . ) is consistent with evidence of increased comorbidity between these phenotypes (Chang, 2011; Yuce et al., 2014) . There is a paucity of clinical studies directly assessing the relationship between SZ and PBC (rg = 0.14 AE 0.05, p = 2.0
). On the other hand, the correlation between SZ and SLE (rg = 0.15 AE 0.04, p = 2.0 × 10 −4 ) appears to be supported by both epidemiological evidence of increased comorbidity (Tiosano et al., 2016) and the well-documented ( The present study identified a number of intriguing and previously unreported genetic correlations, some of which appear to localize near established risk factors for complex disease. On the whole, these findings are consistent with the idea that similar signatures of common genetic variation may increase risk for both psychiatric and immune-related disorders. However, it is important to keep in mind that these findings do not necessarily imply causality or even shared genetic etiology. SNP-based genetic correlations could arise from a wide variety of underlying factors, including the possibility that the relationship between phenotypes is mediated by behavioral or cultural factors, or influenced by a heritable but unexamined underlying trait that confers risk to both phenotypes (Anttila, 2016; Bulik-Sullivan, Finucane, et al., 2015a) . Other factors that could contribute to genetic correlations include effects mediated by parental genotypes and their influence on parental behaviors that impact the offspring (Coop & Pickrell, 2016) . Additionally, GWAS studies of psychiatric phenotypes typically do not screen affected cases on the presence of other medical conditions (and vice versa), thus over-representation of a given phenotype in the sample of another phenotype could bias the data toward the detection of a genetic correlation. Finally, estimates of genetic similarities could be influenced by misdiagnosed cases (Wray, Lee, & Kendler, 2012) . Other general limitations of this method (in comparison with other approaches) have been discussed previously elsewhere (Anttila, 2016; Bulik-Sullivan, Finucane, et al., 2015a) . In light of the exploratory nature of the present study, 
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